๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Stereotactic radiosurgery as a therapeutic strategy for intracranial metastatic prostate carcinoma

โœ Scribed by Thomas Flannery; Hideyuki Kano; Ajay Niranjan; Edward A. Monaco; John C. Flickinger; L. Dade Lunsford; Douglas Kondziolka

Publisher
Springer US
Year
2009
Tongue
English
Weight
229 KB
Volume
96
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Stereotactic radiosurgery as a salvage t
Stereotactic radiosurgery as a salvage treatment for locally persistent and recurrent nasopharyngeal carcinoma
โœ Daniel T.T. Chua; Jonathan S.T. Sham; K.N. Hung; Dora L.W. Kwong; Philip W.K. Kw ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 138 KB

Background. The purpose of this work was to study the efficacy of stereotactic radiosurgery as a salvage treatment in patients with locally persistent and recurrent nasopharyngeal carcinoma (NPC). Methods. Between March 1996 and August 1997, 10 patients with locally persistent or recurrent NPC were

Living donor liver transplantation as a
Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma
โœ Yasutsugu Takada; Mikiko Ueda; Takashi Ito; Seisuke Sakamoto; Hironori Haga; Yoj ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 220 KB ๐Ÿ‘ 1 views

Living donor liver transplantation (LDLT) has evolved to represent an important surgical strategy for patients with hepatocellular carcinoma (HCC). However, due to disadvantages, including donor risks and higher rates of perioperative complications, LDLT has been considered as a second-line treatmen

A Phase II study of oral idarubicin as a
A Phase II study of oral idarubicin as a treatment for metastatic hormone-refractory prostate carcinoma with special focus on prostate specific antigen doubling time
โœ Hans-Peter Schmid; Rudolf Maibach; Juerg Bernhard; Franz Hering; Silvia Hanselma ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 108 KB ๐Ÿ‘ 2 views

## Background: Treatment of hormone-refractory prostate carcinoma with chemotherapy is purely palliative, and reported response rates have been low. at the time this study was conducted, there was an urgent need for a trial using potentially efficacious drugs, with quality of life (ql), and serial